Cargando…

EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer

BACKGROUND: GPRC5A is a retinoic acid inducible gene that is preferentially expressed in lung tissue. Gprc5a– knockout mice develop spontaneous lung cancer, indicating Gprc5a is a lung tumor suppressor gene. GPRC5A expression is frequently suppressed in majority of non-small cell lung cancers (NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xiaofeng, Zhong, Shuangshuang, Ye, Xiaofeng, Liao, Yueling, Yao, Feng, Yang, Xiaohua, Sun, Beibei, Zhang, Jie, Li, Qi, Gao, Yong, Wang, Yifan, Liu, Jingyi, Han, Baohui, Chin, Y Eugene, Zhou, Binhua P, Deng, Jiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200229/ https://www.ncbi.nlm.nih.gov/pubmed/25311788 http://dx.doi.org/10.1186/1476-4598-13-233

Ejemplares similares

Epithelial neoplasia coincides with exacerbated injury and fibrotic response in the lungs of Gprc5a-knockout mice following silica exposure
por: Wang, Xiaofei, et al.
Publicado: (2015)

NF-κB represses retinoic acid receptor–mediated GPRC5A transactivation in lung epithelial cells to promote neoplasia
por: Song, Hongyong, et al.
Publicado: (2023)

Gprc5a-knockout mouse lung epithelial cells predicts ceruloplasmin, lipocalin 2 and periostin as potential biomarkers at early stages of lung tumorigenesis
por: Sun, Beibei, et al.
Publicado: (2017)

PTGES/PGE(2) signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model
por: Wang, Tong, et al.
Publicado: (2020)

Autocrine epiregulin activates EGFR pathway for lung metastasis via EMT in salivary adenoid cystic carcinoma
por: Liu, Shuli, et al.
Publicado: (2016)

Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma
por: Liu, Shuli, et al.
Publicado: (2017)

GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer
por: Mei, Jie, et al.
Publicado: (2023)

SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma
por: Venugopalan, Abhilash, et al.
Publicado: (2021)

circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide
por: Gu, Chaohui, et al.
Publicado: (2018)

G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma
por: Liu, Shuli, et al.
Publicado: (2015)

Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation
por: Barta, Peter, et al.
Publicado: (2012)

GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis
por: Wang, Jian, et al.
Publicado: (2016)

The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
por: Bai, Hao, et al.
Publicado: (2017)

The emerging roles of GPRC5A in diseases
por: Zhou, Honglei, et al.
Publicado: (2014)

GPRC5B-Mediated Sphingomyelin Synthase 2 Phosphorylation Plays a Critical Role in Insulin Resistance
por: Kim, Yeon-Jeong, et al.
Publicado: (2018)

Impaired Osteoblast Function in GPRC6A Null Mice
por: Pi, Min, et al.
Publicado: (2010)

The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer
por: Liu, Bin, et al.
Publicado: (2018)

Computationally identified novel agonists for GPRC6A
por: Pi, Min, et al.
Publicado: (2018)

GPRC5A: An Emerging Biomarker in Human Cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2018)

Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment
por: Foggetti, Giorgia, et al.
Publicado: (2022)

Comparative Functional Genomics Analysis of NNK Tobacco-Carcinogen Induced Lung Adenocarcinoma Development in Gprc5a-Knockout Mice
por: Fujimoto, Junya, et al.
Publicado: (2010)

GPRC6A: Jack of all metabolism (or master of none)
por: Pi, Min, et al.
Publicado: (2016)

GPRC5B protects osteoarthritis by regulation of autophagy signaling
por: He, Liang, et al.
Publicado: (2023)

Phosphorylation by IKKβ Promotes the Degradation of HMGCL via NEDD4 in Lung Cancer
por: Zhong, Chenxi, et al.
Publicado: (2023)

Canine parvovirus induces G1/S cell cycle arrest that involves EGFR Tyr1086 phosphorylation
por: Dai, Xiaofeng, et al.
Publicado: (2020)

STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway
por: Xu, Hui, et al.
Publicado: (2021)

Protein Phosphorylation Profiling Using an In Situ Proximity Ligation Assay: Phosphorylation of AURKA-Elicited EGFR-Thr654 and EGFR-Ser1046 in Lung Cancer Cells
por: Chen, Tzu-Chi, et al.
Publicado: (2013)

Quercetin Attenuates Osteoporosis in Orchiectomy Mice by Regulating Glucose and Lipid Metabolism via the GPRC6A/AMPK/mTOR Signaling Pathway
por: Sun, Jie, et al.
Publicado: (2022)

Role of GPRC6A in Regulating Hepatic Energy Metabolism in Mice
por: Pi, Min, et al.
Publicado: (2020)

GPRC6A Mediates Glucose and Amino Acid Homeostasis in Mice
por: He, Yumin, et al.
Publicado: (2022)

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations
por: Yang, Zhengyu, et al.
Publicado: (2021)

A case report of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with T790M mutation and epithelial-to-mesenchymal transition
por: Zhang, Nana, et al.
Publicado: (2017)

Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma
por: Wang, Hongyan, et al.
Publicado: (2018)

Comparison of Gefitinib in the treatment of patients with non-small cell lung cancer and clinical effects of Osimertinib and EGFR Gene mutation
por: Li, Xiaofeng, et al.
Publicado: (2022)

EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer
por: Kang, JiHoon, et al.
Publicado: (2022)

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma
por: Zhou, Wensheng, et al.
Publicado: (2022)

Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis
por: Lou, Yuqing, et al.
Publicado: (2021)

Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
por: Xia, Jinjing, et al.
Publicado: (2017)

EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer
por: Zhang, Jiqin, et al.
Publicado: (2017)

Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5
por: He, Siwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3h78otrb3ouirjkaqqbq90ni1g